A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors.

Stephen V LiuSusan G GroshenKaren KellyKaren L ReckampChandra BelaniTimothy W SynoldAmir GoldkornBarbara J GitlitzMihaela C CristeaI-Yeh GongThomas J SemradYucheng XuTong XuMarianna KoczywasDavid R GandaraEdward M Newman

Published in: Cancer chemotherapy and pharmacology (2018)

The combination of topotecan and oral tivantinib was not tolerable in this patient population.

Keyphrases

case report
study protocol
phase iii
clinical trial
phase ii
randomized controlled trial